Mapping proteomic composition at distinct genomic loci and subnuclear 40 landmarks in living cells has been a long-standing challenge. Here we report that 41 dCas9-APEX2 Biotinylation at genomic Elements by Restricted Spatial Tagging (C-42 BERST) allows the unbiased mapping of proteomes near defined genomic loci, as 43 demonstrated for telomeres. C-BERST enables the high-throughput identification 44 of proteins associated with specific sequences, facilitating annotation of these 45 factors and their roles in nuclear and chromosome biology. 46 47 48
allowing temporal control over the labeling process. Based in part on the success of dSpyCas9-FP 71 fusions in enabling subnuclear imaging in living cells, we reasoned that a dSpyCas9 derivative 72 that emits radicals rather than photons could be used for subnuclear proteomic analyses in a 73 manner that overcomes the unfavorable kinetics and high background of CasID. Here we use 74 dSpyCas9-APEX2 fusions in the development of C-BERST ( Fig. 1a) for genomic element-75 specific profiling of subnuclear proteomes in live cells. 76
To develop and validate this method, we sought genomic elements that are associated 77 with a well-defined suite of known protein factors, and that can be bound with dSpyCas9 with 78 high efficiency and specificity using an established sgRNA. For this purpose, we chose to target 79 telomeres in human U2OS cells. As with ~10-15% of cancer cell types, U2OS cells rely on 80 alternative lengthening of telomeres (ALT) pathways to maintain telomere length without 81 telomerase activation 7 . Cohorts of proteins associated with telomeres in ALT+ cells are well-82 characterized and map to key pathways such as homologous recombination (HR) and break-83 induced telomere synthesis 8 . Furthermore, an sgRNA (sgTelo) has already been established for 84 efficient telomere association of dSpyCas9 9, 10 . 85
We transduced U2OS cells with a lentiviral vector expressing dSpyCas9 under the 86 control of a tet-on CMV promoter and fused to five nuclear localization signals (NLSs), a ligand-87 tunable degradation domain (DD) 11 , mCherry, and APEX2 ( Fig. 1b) . Maximal expression of 88 this dSpyCas9-mCherry-APEX2 fusion protein requires not only doxycycline (dox) but also the 89 Shield1 ligand to inactivate the DD in a dose-dependent fashion 12 . This combination allows 90 precise control over dSpyCas9-mCherry-APEX2 protein levels for optimal signal-to-noise levels. 91 mCherry-positive cells [collected by fluorescence-activated cell sorting (FACS)] were then 92 transduced with a separate lentiviral vector that included an sgRNA construct (driven by the U6 93 promoter) as well as a blue fluorescent protein (BFP) construct that also expresses the TetR 94 repressor (Fig. 1b) . In one version of this construct the sgRNA cassette encodes sgTelo (for 95 labeling telomeres), and in the other it encodes a non-specific sgRNA (sgNS) that is 96 complementary to a bacteriophage-derived sequence that is absent from the human genome 13 . 97
After 21h of dox and Shield1 induction, we again used fluorescence-activated sorting (FACS) to 98 sort four distinct BFP/mCherry double-positive cell populations (P1-P4) that correlate with 99 different expression levels of dSpyCas9-mCherry-APEX and BFP (as a surrogate for sgRNA and 100 TetR) ( Fig. 1c and Supplementary Fig. 1 ). We reasoned that our signal-to-noise ratio of 101 telomeric vs. non-telomeric biotinylation would be maximized when sgTelo levels are saturating, 102 and when dSpyCas9-mCherry-APEX2 levels are limiting (relative to potential genomic binding 103 sites). Both conditions are expected to favor maximal partitioning of the sgRNA-programmed 104 dSpyCas9-mCherry-APEX into the desired telomere-associated state, with as little unlocalized or 105 mislocalized fusion protein as possible. Visual inspection by fluorescence microscopy (Fig. 1d ) 106 confirmed that the sgTelo P1 cell population (with higher BFP expression and lower mCherry 107 expression) exhibited the most robust mCherry-labelled telomeric foci with the lowest amount of 108 nucleolar or diffuse nucleoplasmic background 9 . We therefore used this population in our 109 subsequent experiments. Diffuse nucleoplasmic labeling, as opposed to distinct foci, was observed 110 in the sgNS P1 population (Fig. 1d) . APEX2-catalyzed biotinylation of nucleoplasmic proteins in 111 the sgNS control sample serves as a reference, permitting an assessment of the telomere 112 specificity of labeling in the sgTelo sample. 113
We induced APEX2-catalyzed biotinylation with biotin-phenol and H2O2 in the sgTelo 114 and sgNS P1 cells, and also included an sgTelo control in which the H2O2 was omitted. Nuclei 115 were isolated from these cells (to reduce cytoplasmic background), and nuclear proteins were 116 then extracted. Recovered proteins (50 µg) were subjected to western analysis using streptavidin-117 conjugated horseradish peroxidase (streptavidin-HRP) ( Fig. 1e) , as well as total protein 118 visualization by Coomassie staining (Fig. 1f ). Samples were also probed with anti-mCherry 119 antibodies (to detect dSpyCas9-mCherry-APEX2) and HDAC1 (as a loading control) ( Fig. 1e , 120 bottom). Biotinylated proteins were readily detected in both sgTelo and sgNS samples, but were 121 largely absent in the -H2O2 control (Fig. 1e) . In the sgNS sample, anti-mCherry and 122 streptavidin-HRP signals were less intense in comparison with the sgTelo sample, indicating that 123 dSpyCas9-mCherry-APEX2 accumulation and activity are lower in the former. Biotinylated 124 proteins were then isolated using streptavidin beads and analyzed by SDS-PAGE and silver 125 staining ( Fig. 1g) . Aside from the ~75kDa endogenously biotinylated proteins routinely detected 126 in SRET-labeled samples 5, 6 , only background levels of proteins were detected in the no-H2O2 127 control sample, indicating successful purification. All three samples were subjected to in-gel 128 trypsin digestion followed by LC-MS/MS to identify the biotin-labeled proteins. These analyses 129
were done with two biological replicates prepared on different days. 130
The two sgTelo replicates yielded at least two unique peptides from 1,106 and 958 131 proteins, >80% of which (876) were detected in both. For these 876 proteins, we used intensity-132 based absolute quantification (iBAQ) values to determine the degree of enrichment in the sgTelo 133 sample relative to the sgNS sample. Some of these 876 proteins (140 in the first replicate, and 134 403 in the second) yielded no spectra whatsoever in the corresponding sgNS sample, consistent 135 with sgTelo specificity. In those cases, to avoid infinitely large sgTelo/sgNS enrichment scores, 136
we assigned those proteins the smallest non-zero iBAQ value from the proteins positively 137 identified in that sgNS dataset. The sgTelo/sgNS iBAQ ratios were then analyzed by moderated 138 t-test, yielding 192 proteins whose enrichment in sgTelo was statistically significant (p < 0.05) 139
[ Fig. 2a (red and blue dots) and Supplementary Table 1 ]. Strikingly, the six subunits of the 140 shelterin complex (a telomere-binding complex that protects ends from chromosome fusion 14 ) 141
were the six most significantly enriched proteins ( Fig. 2a and Supplementary Table 1 ). 142
Another highly enriched protein was Apollo, a 5'à3' exonuclease that interacts with the 143 shelterin component TRF2 and functions in the ALT pathway 15 . Overall, among the 192 most 144 significantly sgTelo-enriched proteins ( Supplementary Table 1 ), 32 have been reported 145 previously to be associated with telomeres or linked to telomere function (Supplementary 146 Table 1 ). These include proteins from complexes known to contribute to ALT-associated 147 pathways or processes ( Supplementary Fig. 2 ). Gene ontology (GO) analysis of the 192 C-148 BERST proteomic hits reveals strong functional associations with terms such as telomere 149 maintenance, DNA replication, DNA repair, and homologous recombination, all of which are 150 important for ALT pathways 7 (Fig. 2b) . 151
Telomere-associated proteomes from ALT+ cell lines have been defined previously by 152 TRF1-BirA* BioID in U2OS cells 16 , and by biochemical purification [proteomics of isolated 153 chromatin segments (PICh)] from WI38-VA13 cells 17 . Protein identifications from these analyses, 154 as well as from our C-BERST dataset, were examined for overlap as depicted in the Venn 155 diagram shown in Fig. 2c . Of the 192 proteins identified by C-BERST, 74 (~38%) were also 156 detected by one or both of the other methods [62 by BioID (p = 7.02 x 10 -56 ), 31 by PICh (p = 157 1.58 x 10 -30 ), and 19 by both]. Of the 19 proteins detected by all three approaches ( Fig. 2d) (NOSIP), SLX4-interacting protein (SLX4IP), and core-binding factor subunit beta (CBFB) ( Fig.  162 2d)] appear likely to have previously unappreciated roles as telomere-associated factors. 163
In conclusion, we demonstrate that C-BERST successfully maps subnuclear proteomes 164 associated with genomic landmarks. Using the extensively investigated ALT telomeric proteome 165 as a benchmark, we recover approximately 41% of known ALT-associated proteins (32 of 78, 166 Supplementary Tables 1 and 2) , as well as factors involved in all reported biological 167 processes that contribute to ALT. By combining the flexibility of RNA-guided dSpyCas9 genome 168 binding with the efficiency and rapid kinetics of APEX2-catalyzed biotinylation, C-BERST 169 promises to extend the unbiased definition of subnuclear proteomes to many genomic elements, 170
and to a range of dynamic processes (e.g. cellular differentiation, responses to extracellular stimuli, 171
and cell cycle progression) that occur too rapidly to analyze via the 18-24h labeling procedures 172 inherent to CasID. Importantly, C-BERST promises to augment and extend Hi-C and related 173 methods by linking conformationally important cis-elements with the factors that associate with 174 them. Our initial implementation of C-BERST focused on minimizing the background labeling 175 catalyzed by un-or mis-localized dSpyCas9-mCherry-APEX2, mostly by optimizing its 176 expression level relative to that of its sgRNA. This method is amenable to further improvements 177 including isotope labeling 5 or tandem mass tagging 18 that will enable ratiometric assessments of 178 differential biotinylation when dSpyCas9-mCherry-APEX2 is guided by specific vs. non-specific 179 sgRNAs. Such improvements, in conjunction with sgRNA multiplexing, may prove to be 180 important for applying C-BERST to the definition of subnuclear proteomes associated with non-181 repetitive loci. In the meantime, many types of repetitive elements within the genome, like 182 telomeres, play critically important roles in chromosome maintenance and function in ways that 183 depend upon associated proteins; C-BERST provides an unbiased method for sampling 184 subnuclear, locus-specific proteomics at these elements to define protein factors critical to the 185 functions of these elements. 186
187

METHODS 188
Methods, data files, and any associated references are available in the online version of the paper. Supplementary Fig. 1b) were sorted into plates containing 1% GlutaMAX, 20% FBS, and 1% 259 penicillin/streptomycin in DMEM medium. transformed iBAQ values between S1 and S3, S1 and S2, and S2 and S3 using limma package 23 . 341
To adjust for multiple comparisons, p values were adjusted using the Benjamini-Hochberg (BH) 342 method 24 . Proteins with BH-adjusted p values less than 0.05 are considered statistically significant. 343
Proteins were selected for subsequent GO (David Bioinformatics) and overlap analysis if they 344 were (i) significantly enriched in both S1 vs. S3 and S1 vs. S2, (ii) not enriched in S2 vs. S3, and 345 (iii) if S1/S3 and S1/S2 ratios were greater than 2. To determine whether the proteins identified 346 in this experiment overlap significantly with two published datasets, a hypergeometric test was 347 used. H2O2 and sgNS + H2O2 samples (see Supplementary Table 1 ). Proteins denoted by single 418 asterisks were also detected but with lower degrees of enrichment (BH-adjusted p value > 0.05) in 419 the sgTelo + H2O2 sample (Supplementary Table 1 ). Components of the 420 RAD9/RAD1/HUS1 complex (see Supplementary Table 2 ) were not detected. 
Amino acid sequence of dSpyCas9-mCherry-APEX2
Legend: NLS DD dSpyCas9 mCherry FLAG APEX2 MAPKKKRKVEDKRPAATKKAGQAKKKKEDACGVQVETISPGDGRTFPKRGQTCVVHYTGMLE  DGKKVDSSRDRNKPFKFMLGKQEVIRGWEEGVAQMSVGQRAKLTISPDYAYGATGHPGIIPPH  ATLVFDVELLKPEGSEFGSGSDKKYSIGLAIGTNSVGWAVITDEYKVPSKKFKVLGNTDRHSIKK  NLIGALLFDSGETAEATRLKRTARRRYTRRKNRICYLQEIFSNEMAKVDDSFFHRLEESFLVEED  KKHERHPIFGNIVDEVAYHEKYPTIYHLRKKLVDSTDKADLRLIYLALAHMIKFRGHFLIEGDLNP  DNSDVDKLFIQLVQTYNQLFEENPINASGVDAKAILSARLSKSRRLENLIAQLPGEKKNGLFGNLI  ALSLGLTPNFKSNFDLAEDAKLQLSKDTYDDDLDNLLAQIGDQYADLFLAAKNLSDAILLSDILRV  NTEITKAPLSASMIKRYDEHHQDLTLLKALVRQQLPEKYKEIFFDQSKNGYAGYIDGGASQEEFY  KFIKPILEKMDGTEELLVKLNREDLLRKQRTFDNGSIPHQIHLGELHAILRRQEDFYPFLKDNREK  IEKILTFRIPYYVGPLARGNSRFAWMTRKSEETITPWNFEEVVDKGASAQSFIERMTNFDKNLPN  EKVLPKHSLLYEYFTVYNELTKVKYVTEGMRKPAFLSGEQKKAIVDLLFKTNRKVTVKQLKEDY  FKKIECFDSVEISGVEDRFNASLGTYHDLLKIIKDKDFLDNEENEDILEDIVLTLTLFEDREMIEERL  KTYAHLFDDKVMKQLKRRRYTGWGRLSRKLINGIRDKQSGKTILDFLKSDGFANRNFMQLIHDD  SLTFKEDIQKAQVSGQGDSLHEHIANLAGSPAIKKGILQTVKVVDELVKVMGRHKPENIVIEMAR  ENQTTQKGQKNSRERMKRIEEGIKELGSQILKEHPVENTQLQNEKLYLYYLQNGRDMYVDQEL  DINRLSDYDVDAIVPQSFLKDDSIDNKVLTRSDKNRGKSDNVPSEEVVKKMKNYWRQLLNAKLI  TQRKFDNLTKAERGGLSELDKAGFIKRQLVETRQITKHVAQILDSRMNTKYDENDKLIREVKVIT  LKSKLVSDFRKDFQFYKVREINNYHHAHDAYLNAVVGTALIKKYPKLESEFVYGDYKVYDVRKM  IAKSEQEIGKATAKYFFYSNIMNFFKTEITLANGEIRKRPLIETNGETGEIVWDKGRDFATVRKVL  SMPQVNIVKKTEVQTGGFSKESILPKRNSDKLIARKKDWDPKKYGGFDSPTVAYSVLVVAKVEK  GKSKKLKSVKELLGITIMERSSFEKNPIDFLEAKGYKEVKKDLIIKLPKYSLFELENGRKRMLASA  GELQKGNELALPSKYVNFLYLASHYEKLKGSPEDNEQKQLFVEQHKHYLDEIIEQISEFSKRVIL  ADANLDKVLSAYNKHRDKPIREQAENIIHLFTLTNLGAPAAFKYFDTTIDRKRYTSTKEVLDATLI  HQSITGLYETRIDLSQLGGDGSTSGSPKKKRKVGSGSMVSKGEEDNMAIIKEFMRFKVHMEGS  VNGHEFEIEGEGEGRPYEGTQTAKLKVTKGGPLPFAWDILSPQFMYGSKAYVKHPADIPDYLK  LSFPEGFKWERVMNFEDGGVVTVTQDSSLQDGEFIYKVKLRGTNFPSDGPVMQKKTMGWEA  SSERMYPEDGALKGEIKQRLKLKDGGHYDAEVKTTYKAKKPVQLPGAYNVNIKLDITSHNEDYT  IVEQYERAEGRHSTGGMDELYKSGGRGGGGSDYKDDDDKGKSYPTVSADYQDAVEKAKKKL  RGFIAEKRCAPLMLRLAFHSAGTFDKGTKTGGPFGTIKHPAELAHSANNGLDIAVRLLEPLKAEF  PILSYADFYQLAGVVAVEVTGGPKVPFHPGREDKPEPPPEGRLPDPTKGSDHLRDVFGKAMGL  TDQDIVALSGGHTIGAAHKERSGFEGPWTSNPLIFDNSYFTELLSGEKEGLLQLPSDKALLSDP  VFRPLVDKYAADEDAFFADYAEAHQKLSELGFADALEPKKKRKVEDKRPAATKKAGQAKKKKG  S* 
